Skip to main content
. 2022 Apr 19;14(1):2064705. doi: 10.1080/19490976.2022.2064705

Table 3.

List of primers used in this study

Gene Sequence (5’-3’) Reference
katG catR F:ACTTCCCGTTGCCAGCGCCTCTTTCATTATAACCCTGTGTTTATTATGAAGTGTAGGCTGGAGCTGCTTC
R:AGCATCGTTTTTGCCAATTCCCTCCCCGAATGAGGGAGGGAAGGTTGCCAATGGGAATTAGCCATGGTCC
This study
katG-Flanking F: ACTTCCCGTTGCCAGCGCCTCTTTC
R: AGCATCGTTTTTGCCAATTCCCTCC
This study
katG-Inner F: GACGGTAAACCCGTCACCAG
R: ACTCCCGGTACGTTCAGACT
This study
clpP catR F:TTGAGGGATGACCTCATTTAATCTCCAGTAGCAATTTTGACCTGTTATGGGTGTAGGCTGGAGCTGCTTC
R:TTTTAAACAAAAACGAGCCCGTCAGGGCCCGTTTTATTCAAATTTGTGACATGGGAATTAGCCATGGTCC
This study
clpP- Flanking F: ATTACCACCACCGCATACC
R: GCTTCGACTATCTCAGCTAAC
This study
clpP-Inner F: TCAATAAATCACATCCCAAGCC
R: CCCTTCAGCAAAATTAAGCATC:
This study
ftsH catR F:TGACGCTGTTTTTAACACAGTTGTAATAAGAGGTTAATCCCTTGAGTGACGTGTAGGCTGGAGCTGCTTC
R:AAGCCCCAGGGTTTCGGTGAGCGCTAAACATAATGTTGTAAAACAAATGCATGGGAATTAGCCATGGTCC
This study
FtsH- Flanking F: GCGAAAGTGATAACCGGCAG
R: CGGATGAGTGAGATCGAGCG
This study
FtsH- Inner F: GGGTTGTGACGAAGCGAAAG
R: AAGCCGTCCATCTCAACCAG
This study
hsIUV catR F:TGCATTATGCCCCGTACGCCGTACGGGGCCGCAATTCAGCATTAGTAACCGTGTAGGCTGGAGCTGCTTC
R:TTCAGTTCGCTGACAATTTCGCGTGGGGTCATTTCAGACATGAGAGGTCCATGGGAATTAGCCATGGTCC
This study
hsIUV-Flanking F: AAGATGGCGGGCCATACAAA
R: CATCAAGCTGCATACGACGC
This study
hsIUV – Inner F: GGCAACGTGAAGAAAGTCCG
R: GCCTGCAATATCCAACGCCT
This study
KatG (pET28) F: GAATTCATGAGCACGACCGACGATAC
R: AAGCTTGCTGCCGTCAAAGTTGGTTC
This study
LonPD (pET28) F: GCGAATTCGAAAACCGCGTAGGT
R: GGAAGCTTGTTTTGCAGAGCAAG
This study
B2H primers    
katG F: CGGGATCCCATGAGCACGACCGACGAT
R: CGGGTACCGCTTGCAGATCGAAACGGTC
This study
Lon PD F: CGGGATCCCGAAAACCGCGTAGGTCAG
R: CGGGTACCGCGTTTTGCAGAGCAAGCGT
This study
katG (1–206)* F: CGGGATCCCATGAGCACGACCGACGAT
R: CGGGTACCGCGTGAGTCAACCAGGCTTT
This study
katG (1–207) F: CGGGATCCCATGAGCACGACCGACGAT
R: CGGGTACCGCTCGGTGAGTCAACCAGGCT
This study
katG (1–208) F: CGGGATCCCATGAGCACGACCGACGAT
R: CGGGTACCGCGTGTCGGTGAGTCAACCA
This study
katG (1–209) F: CGGGATCCCATGAGCACGACCGACGAT
R: CGGGTACCGCAGGGTGTCGGTGAGTCAAC
This study
katG (1–210) F: CGGGATCCCATGAGCACGACCGACGAT
R: CGGGTACCGCTTCAGGGTGTCGGTGAGTC
This study
katG (1–211) F: CGGGATCCCATGAGCACGACCGACGAT
R: CGGGTACCGCCGCTTCAGGGTGTCGGTGA
This study
katG (1–379) F: CGGGATCCCATGAGCACGACCGACGAT
R: CGGGTACCGCCGTCAGGTCGGTGACCAG
This study
katG (1–380) F: CGGGATCCCATGAGCACGACCGACGAT
R: CGGGTACCGCCAGCGTCAGGTCGGTGAC
This study
katG (1–381) F: CGGGATCCCATGAGCACGACCGACGAT
R: CGGGTACCGCACGCAGCGTCAGGTCGGT
This study
katG (1–382) F: CGGGATCCCATGAGCACGACCGACGAT
R: CGGGTACCGCAAAACGCAGCGTCAGGTC
This study
katG (1–383) F: CGGGATCCCATGAGCACGACCGACGAT
R: CGGGTACCGCATCAAAACGCAGCGTCAG
This study
katG (1–384) F: CGGGATCCCATGAGCACGACCGACGAT
R: CGGGTACCGCCGGATCAAAACGCAGCGT
This study
qRT-PCR    
Salmonella    
rrsG F: GTTACCCGCAGAAGAAGCAC
R: CACATCCGACTTGACAGACC
This study
sopE F: TTCAAGCCCCACTTCAAGCC
R: TGAGTCAAATCCAGAACATGCC
This study
sseJ F: ACGGATGCGACAAAAATCAC
R: ACCTTGGAAGCCCTACAGAC
This study
sifA F: AGACAATGAACGCTACACAC
R: TCTTTTCTTCCACATCTATGCC
This study
invC F: GACAACATACTGCTAACCGAC
R:ATCACTCTTCACCTGCTCC
This study
katE F: ATTCCGGAAGAGTTGGTGCCAGTA
R: GACGACTGATTTGCGTGTCGGTAT
51
katN F: GCGCGAGCGAAGATCATTTAT
R: GCGACTTCACGGGTCATTAAGA
51
katG F: TTAACTCCTGGCCGGATAAC
R: TAATCGGCCACAACAAACG
51
TsaA/ahpC F: TTTGTTTGCCCGACTGAACTGG
R: TGTGCGTGAAGTGAGTATCGGT
51
ahpF F: GGCTATCGATCTGGCAGGTATTGT
R: TACGCACTTTGTCCTGTAGCA
51
Mouse    
IL-2 F: CCTGAGCAGGATGGAGAATTACA
R: TCCAGAACATGCCGCAGAG
52
IL-6 F: GAGGATACCACTCCCAACAGACC
R: AAGTGCATCATCGTTGTTCATACA
52
TNF-α F: CATCTTCTCAAAATTCGAGTGACAA
R: TGGGAGTAGACAAGGTACAACCC
52
GAPDH F: TCACCACCATGGAGAAGGC
R: GCTAAGCAGTTGGTGGTGCA
52
Human    
IL-2 F: AACTCACCAGGATGCTCACATTTA
R: TCCCTGGGTCTTAAGTGAAAGTTT
52
IL-6 F: CATCCTCGACGGCATCTCAG
R: GCTCTGTTGCCTGGTCCTC
53
TNF-α F: TCTTCTCGAACCCCGAGTGA
R: CCTCTGATGGCACCACCAG
52
GAPDH F: GGAAGGTGAAGGTCGGAGTC
R: CAGCCTTGACGGTGCCATG
53

F-Forward primer; R- Reverse primer. *The numbers in parenthesis indicate corresponding amino acid residues.